Clinical trials recruiting in Hwaseong-si, South Korea

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions recruiting in Hwaseong-si, South Korea

Recruiting trials in Hwaseong-si, South Korea

• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  NCT06641466 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female
• ICG Lymphoscintigraphy Changes Before and After Radiotherapy in Breast Cancer Patients
  NCT07297927 · Phase: Not specified · Ages: 18 Years and older · Sex: Female
• Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease
  NCT07239310 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
  NCT06603558 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hwaseong-si, South Korea?

2 recruiting trials have at least one study site in Hwaseong-si, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.